Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
- PMID: 32283315
- PMCID: PMC7151236
- DOI: 10.1016/j.jtho.2020.04.001
Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
Comment in
-
Coronavirus Disease 2019 or Lung Cancer: A Differential Diagnostic Experience and Management Model From Wuhan.J Thorac Oncol. 2020 Aug;15(8):e141-e142. doi: 10.1016/j.jtho.2020.04.030. Epub 2020 May 7. J Thorac Oncol. 2020. PMID: 32387713 Free PMC article. No abstract available.
-
The Management of Patients With Lung Cancer During the Outbreak of Coronavirus Disease 2019.J Thorac Oncol. 2020 Jul;15(7):e106-e107. doi: 10.1016/j.jtho.2020.05.003. Epub 2020 May 23. J Thorac Oncol. 2020. PMID: 32482585 Free PMC article. No abstract available.
References
-
- Zhang H, Huang Y, Xie C. The treatment and outcome of a lung cancer patient infected with SARS-CoV-2 [e-pub ahead of print]. J Thorac Oncol. https://doi.org/10.1016/j.jtho.2020.02.025, accessed April 17, 2020. - DOI
-
- Postow M.A., Sidlow R., Hellmann M.D. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378:158–168. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical